IMPACT Trial: Intervention to iMProve AdherenCe Equitably

NARecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

March 2, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
Breast Cancer
Interventions
BEHAVIORAL

Multicomponent Adherence Intervention

The adherence intervention will be comprised of a participant preference approach in which all participants undergo a baseline pharmacist-led medication optimization session and are offered training in how to use the patient portal and freely-available smartphone reminder app.

OTHER

Usual Care

Receipt of usual care from providers

Trial Locations (1)

10032

RECRUITING

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

Columbia University

OTHER